As discussed below and shown in Table 1 and  Table 2, c-FLIP variants can be inhibited by compounds that inhibit their transcription or translation, trigger their degradation, or by c-FLIP-specific small interfering RNA (siRNA) which sensitize a wide range of cancer cell types to TRAIL and chemotherapy-induced apoptosis. Here, CFLAR is linked to cancer.